EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The renal response to FGF23 shifts from phosphaturia toward inflammation in kidney disease

Matthias B Moor iD, Mikhail Burmakin iD, Anna Levin iD, Gül Gizem Korkut, David Brodin iD, Annika Wernerson iD, Annette Bruchfeld iD, Peter Bárány iD, Anna Witasp iD, Jaakko Patrakka, Hannes Olauson iD

Journal of Cell Communication and Signaling · 2026-03 · 20 (1)

DOI: 10.1002/ccs3.70061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cell Communication and Signaling, online erschienen am 23.02.2026. Verfasst von Matthias B Moor und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Renal Medicine Department of Clinical Science Intervention and Technology Karolinska Institutet Stockholm Sweden. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Karolinska Institutet, Novo Nordisk Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

FGF23 excess is associated with morbidity and mortality, but the role of excessive circulating FGF23 concentrations as a causative factor of pathology is controversial. Here, we investigated the consequences of FGF23 excess in kidney disease. This study used three disease models: anti‐glomerular basement membrane (anti‐GBM) disease, Adriamycin nephropathy, and adenine‐containing diets. Anti‐GBM and Adriamycin mice and matched control mice received recombinant FGF23 (1 µg) or vehicle for six days (anti‐GBM) or once (Adriamycin model), with dissection 24 h after the last injection. We established precision‐cut kidney slices (PCKS) in adenine nephropathy for 24 h of treatment with recombinant FGF23 or vehicle. We assessed serum cytokines, biochemistry, and renal transcriptomes and histology of mice and patients with IgA nephropathy. RNA‐Seq data and published transcriptomes underwent gene set enrichment, bulk ligand–receptor interaction analysis, and cell‐type decomposition. Experimental anti‐GBM disease caused decreased glomerular filtration rate, albuminuria, and renal tubular casts. FGF23 treatment increased phosphaturia and circulating soluble tumor necrosis factor receptor 1. The anti‐GBM model showed FGF23‐driven proinflammatory transcriptional signatures and Vcam1, Pdgfrb, and chemokine signaling, which were absent in FGF23‐treated healthy mice. FGF23 increased renal macrophage content by transcriptome deconvolution and by immunofluorescence. In Adriamycin‐induced nephropathy and in PCKS from adenine nephropathy, short‐term FGF23 excess increased proinflammatory transcripts. Human data revealed associations between circulating FGF23 and renal immune cell infiltration. We found FGF23‐driven renal patterns of proinflammatory gene and protein expression or leukocyte overabundance. The present data provide evidence that excess FGF23 directly drives inflammation in kidney disease and may serve as a therapeutic target.

Schlagwörter

Stichwörter der Autor:innen

FGF23RNA deconvolutioncytokinesinflammationkidney diseaseproteinuria

Autor:innen und Institutionen

  • Division of Renal Medicine Department of Clinical Science Intervention and Technology Karolinska Institutet Stockholm Sweden.
  • Division of Pathology Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden.
  • Department of Nephrology and Hypertension University Hospital Bern and University of Bern Bern Switzerland.
  • Bioinformatics and Expression Analysis Core Facility (BEA) Karolinska Institutet Huddinge Sweden.
  • Department of Health Medicine and Caring Sciences Linköping University Linköping Sweden.

ORCID-Profile: Matthias B Moor, Mikhail Burmakin, Anna Levin, David Brodin, Annika Wernerson, Annette Bruchfeld, Peter Bárány, Anna Witasp, Hannes Olauson

Förderung

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Karolinska Institutet
  • Novo Nordisk Fonden
  • Stiftelsen Stig och Gunborg Westman
  • Stiftelsen Professor Lars-Erik Gelins Minnesfond
  • Center for Innovative Medicine
  • Njurfonden

Zitieren

APA

Moor, M. B., Burmakin, M., Levin, A., Korkut, G. G., Brodin, D., Wernerson, A., Bruchfeld, A., Bárány, P., Witasp, A., Patrakka, J., & Olauson, H. (2026). The renal response to FGF23 shifts from phosphaturia toward inflammation in kidney disease. Journal of Cell Communication and Signaling, 20(1). https://doi.org/10.1002/ccs3.70061

Vancouver

Moor MB, Burmakin M, Levin A, Korkut GG, Brodin D, Wernerson A, et al. The renal response to FGF23 shifts from phosphaturia toward inflammation in kidney disease. Journal of Cell Communication and Signaling. 2026;20(1). doi:10.1002/ccs3.70061

BibTeX
@article{Moor2026,
  author = {Moor, Matthias B and Burmakin, Mikhail and Levin, Anna and Korkut, Gül Gizem and Brodin, David and Wernerson, Annika and Bruchfeld, Annette and Bárány, Peter and Witasp, Anna and Patrakka, Jaakko and Olauson, Hannes},
  title = {The renal response to FGF23 shifts from phosphaturia toward inflammation in kidney disease},
  journal = {Journal of Cell Communication and Signaling},
  year = {2026},
  volume = {20},
  number = {1},
  doi = {10.1002/ccs3.70061}
}
Kostenlos starten →